What You Need to Know

• Attorneys from Vogel, Slade & Goldstein and Susman Godfrey announced that Walgreen's, Stephen L. LaFrance Holdings Co. and other companies that were part of USA Drug, a regional pharmacy chain acquired by Walgreens, have agreed to pay $16 million to the United States, Oklahoma and Tennessee to resolve a whistleblower lawsuit.
• The suit was brought by James D. Strauser, a pharmacist who worked at USA Drug, alleging that the pharmacy overcharged government health programs for generic medication.
• As the result of the settlement, the district court dismissed Strauser's qui tam claims against the defendants.

Walgreen’s, Stephen L. LaFrance Holdings and members of the USA Drug pharmacy chain have agreed to pay $16 million to settle a whistleblower lawsuit regarding the alleged overbilling of government health programs, attorneys from Vogel, Slade & Goldstein and Susman Godfrey announced this week.

Vogel, Slade & Goldstein partner of a boutique Washington, D.C.-based firm, Shelley Slade, and Susman Godfrey’s Bill Carmody, a partner based in New York, successfully led the whistleblower lawsuit on behalf of their client, James D. Strauser, a pharmacist who worked at USA Drug, a regional pharmacy chain acquired by Walgreen’s. The case is U.S. ex rel. Strauser, et al. v. Stephen L. LaFrance Holdings Co., et al.

Want to continue reading?
Become an ALM Digital Reader for Free!

Benefits of a Digital Membership

• Free access to 1 article* every 30...

Read Full Story: https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5sYXcuY29tLzIwMjMv...